Raras
Buscar doenças, sintomas, genes...
Botulismo infantil
ORPHA:178478CID-10 · A05.1CID-11 · 1A11.1DOENÇA RARA

Botulismo que ocorre entre 28 dias a um ano de vida.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Botulismo que ocorre entre 28 dias a um ano de vida.

Publicações científicas
485 artigos
Último publicado: 2026 Apr 11

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: A05.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
4 sintomas
🧠
Neurológico
3 sintomas
👁️
Olhos
2 sintomas
💪
Músculos
2 sintomas
📏
Crescimento
1 sintomas
❤️
Coração
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade do movimento
Muito frequente (99-80%)
90%prev.
Paralisia cerebral
Muito frequente (99-80%)
90%prev.
Anorexia
Muito frequente (99-80%)
90%prev.
Diplopia
Muito frequente (99-80%)
90%prev.
Ptose
Muito frequente (99-80%)
90%prev.
Ceratoconjuntivite seca
Muito frequente (99-80%)
31sintomas
Muito frequente (17)
Frequente (7)
Ocasional (4)
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 31 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do movimentoAbnormality of movement
Muito frequente (99-80%)90%
Paralisia cerebralCerebral palsy
Muito frequente (99-80%)90%
Anorexia
Muito frequente (99-80%)90%
Diplopia
Muito frequente (99-80%)90%
PtosePtosis
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico485PubMed
Últimos 10 anos137publicações
Pico202520 papers
Linha do tempo
2026Hoje · 2026🧪 1998Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Botulismo infantil

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
136 papers (10 anos)
#1

The unsung hero: ntnh gene as complementary botulism marker.

Frontiers in cellular and infection microbiology2026

Botulism is a rare but severe neurological disease caused by botulinum neurotoxins (BoNTs). Standard diagnostic methods including the mouse bioassay (SMB) and bont gene type-specific PCR, are often limited by the high genetic diversity among bont subtypes, which can lead to false-negative results. The nontoxin-nonhemagglutinin (ntnh) gene is highly conserved and exclusively co-located with the bont gene complex. Thus, this study evaluates the use of ntnh gene as a complementary diagnostic tool for botulism and assesses its association with BoNT types. The ntnh gene was detected in a prospective BoNT-diagnostic group (n=88) and a BoNT-historical group (n=54). Toxin cluster proteins were identified in GenBank and RefSeq Clostridium proteomes using MMSeqs2. ntnh gene detection reinforced positive results from SMB or bont gene tests in 26 cases (35.62% of the total confirmed cases) of foodborne and infant botulism. In two foodborne cases from the BoNT-diagnostic group, the ntnh gene was detected despite negative results from both SMB and bont gene tests, highlighting its potential to identify missed cases. An in silico analysis of 3,250 RefSeq and 2,494 GenBank annotated Clostridium proteomes was conducted. respectively. So, NTNH showed a high co-presence pattern with BoNT. Moreover, NTNH sequences were far more conserved than BoNT sequences in inter-type comparisons (67.2 vs.39.7), which highlights its applicability as a disease biomarker. The ntnh gene analysis is a valuable complementary tool enhancing the diagnosis of botulism. The study highlights the need for clear guidelines to interpret positive ntnh results when direct toxin or bont gene confirmation are negative.

#2

Multistate Infant Botulism Outbreak Associated with Powdered Infant Formula.

NEJM evidence2026 Apr

AbstractThis report details the identification of an outbreak of infant botulism linked to powdered infant formula in the United States. In October 2025, the Infant Botulism Treatment and Prevention Program, California Department of Public Health (IBTPP-CDPH) noted common powdered infant formula exposure among three neonates with suspected infant botulism. Subsequent laboratory analyses at CDPH identified Clostridium botulinum type A from an open container of ByHeart powdered infant formula associated with one infant with infant botulism. As of December 10, 2025, 51 suspected or confirmed infant botulism cases with exposure to ByHeart powdered infant formula had been identified across 19 states. All ByHeart powdered infant formula has been recalled nationwide.

#3

More Than Just a Floppy Baby: Maintaining High Clinical Suspicion of Infant Botulism.

Cureus2026 Jan

Infant botulism is a rare and life-threatening condition if left untreated. We report the case of a previously healthy four-week-old male in Arkansas, who presented with progressive lethargy, feeding difficulties, and respiratory compromise following a recent viral respiratory illness. His clinical course was notable for worsening hypotonia, absent reflexes, and eventual respiratory failure requiring intubation. Extensive evaluation for infectious, neurologic, and metabolic causes was initially unrevealing, but further exposure history revealed constipation paired with recent soil exposure, raising suspicion for infant botulism. Botulinum immune globulin (BabyBIG®) was administered, with subsequent gradual clinical improvement. Stool testing later confirmed the presence of botulinum toxin type B. The patient was discharged in stable condition, tolerating full oral feeds, and without further complications. This case underscores the diagnostic difficulty of infant botulism due to early age at presentation, anchoring bias with diagnosis of a recent viral illness, and overlapping symptoms with other neonatal conditions. A detailed exposure history is critical, and early clinical suspicion can facilitate timely treatment and improve outcomes.

#4

Infant Honey Feeding and Associating Sociodemographic and Clinical Factors: Are there risks for infant botulism in Oman?

Sultan Qaboos University medical journal2026

This study aimed to assess the risks associated with infant botulism in Oman by examining honey-feeding practices among infants and related sociodemographic and clinical factors. This cross-sectional study included Omani mothers with children under 5 years and were conveniently recruited from health centres. Mothers completed an infant feeding practices and beliefs survey between October 2023 and March 2024. Data were represented as frequencies and percentages and analysed via Chi-square test and logistic regression. A total of 3,222 participants were included of which 58.8% were aged 26-35 years. The study found that 38.7% of children were fed honey during their first year. Local Omani honey was used by 34.6%, often for reasons including cough relief (15.2%), boosting immunity (11.6%) and Tahneek (8.6%). Additionally, 16.7% of mothers felt pressured to introduce honey and 45.9% viewed early honey feeding as acceptable. Multivariate logistic regression analysis revealed that infant honey feeding was negatively and significantly associated with maternal education (odds ratio [OR] = 0.77, 95% confidence interval [CI]: 0.65-0.91; P <0.001), family income (OR = 0.61, 95% CI: 0.51-0.74; P <0.001) and receipt of infant feeding counseling (OR = 0.83, 95% CI: 0.72-0.97; P = 0.007). Additionally, results indicated that infants who were fed honey had a higher likelihood of experiencing constipation (OR = 1.29, 95% CI: 1.10-1.51; P = 0.001) and muscle weakness (OR = 1.84, 95% CI: 1.15-2.95; P = 0.011). This study highlights the potential risks of infant botulism in Oman, emphasising the importance of following updated clinical guidelines for optimal infant care and effective reporting.

#5

Clostridioides difficile colonization of Twin Patients Recovering From Infant Botulism.

Anaerobe2026 Mar

The prevalence of Clostridioides difficile co-colonization of 107 California patients with suspect infant botulism (IB) was studied over a two-year period. One set of twins with lab-confirmed IB and C. difficile co-colonization was followed longitudinally and their isolated C. difficile was typed by restriction endonuclease analysis (REA). Stool specimens sent to California Department of Public Health for routine IB diagnostic testing were cultured for C. botulinum and C. difficile. After diagnostic testing identified twin IB patients, their stools collected at weekly and monthly intervals were cultured to determine duration of C. botulinum and C. difficile co-colonization until three consecutive specimens were culture negative for each organism. Twins X and Y were colonized by C. botulinum for a duration of nearly three and four months, followed by C. difficile for eight and seven months, respectively. Continuous colonization by C. difficile was identified in each twin as C. botulinum colonization was waning. They sequentially shared four identical REA types, three toxigenic and one non-toxigenic, including epidemic strain type J9. Neither twin developed C. difficile illness and colonization ceased spontaneously in each. C. difficile co-colonization of laboratory-confirmed IB patients is infrequently encountered. IB in both twins was followed by asymptomatic C. difficile colonization. Risk factors for their respective co-colonization remain unknown, including if previous illness with IB was a potential contributing factor. Although the environmental source of the colonizing strains was not determined, this study highlights the ability of C. difficile to spread to close contacts and persist in the infant intestinal microbiome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC336 artigos no totalmostrando 133

2025

[Evaluation of ventilatory muscles in infants with severe botulism].

Andes pediatrica : revista Chilena de pediatria
2026

The unsung hero: ntnh gene as complementary botulism marker.

Frontiers in cellular and infection microbiology
2026

Multistate Infant Botulism Outbreak Associated with Powdered Infant Formula.

NEJM evidence
2026

More Than Just a Floppy Baby: Maintaining High Clinical Suspicion of Infant Botulism.

Cureus
2026

Infant Honey Feeding and Associating Sociodemographic and Clinical Factors: Are there risks for infant botulism in Oman?

Sultan Qaboos University medical journal
2026

Clostridioides difficile colonization of Twin Patients Recovering From Infant Botulism.

Anaerobe
2026

Botulism Sequelae: A Systematic Review.

Open forum infectious diseases
2026

Whole-genome sequencing-based typing methods for Clostridium butyricum strains from clinical, animal, plant, and environmental sources.

Microbiology spectrum
2025

Infant Botulism: A Case Study in Integrated Clinical and Public Health Response.

Clinical case reports
2026

Regional Risk Discrepancy Indicates a Slow Outbreak of Infant Botulism, Victoria, Australia.

The Pediatric infectious disease journal
2026

Cultural Persistence of Tahnik Practice (Use of Honey) Despite Infant Botulism Risk: A Community-Based Study in Pakistan.

Journal of community health nursing
2026

Pharmacovigilance and toxicological risks associated with apitherapeutic products: a systematic overview.

Archives of toxicology
2025

Author's response: Peanut butter confirmed as the source of a case of infant botulism in the United Kingdom, 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Features of the First Case of Foodborne Botulism Caused by Dual-Toxin Clostridium parabotulinum Subtype A1(B5) in Spain.

Toxins
2025

Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review.

Journal of neurochemistry
2025

Peanut butter confirmed as the source in a case of infant botulism, United Kingdom, 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Detection of a streptogramin A O-acetyltransferase gene (vatD) in the chromosome of Clostridium botulinum isolated from infants in the United States.

Applied and environmental microbiology
2025

Infant Botulism and Carbohydrate Blood Group Antigens: Preliminary Results from a Discordant Twin Study.

Journal of pediatrics. Clinical practice
2025

Paralysis in Pairs: Insights From Two Cases of Infant Botulism.

Clinical pediatrics
2025

Could Intravenous Immunoglobulin Be an Alternative Therapy for Treating Infant Botulism in Areas Where Human Botulism Immunoglobulin Is Not Easily Available?: Our Experience in Andalusia, Spain.

The Pediatric infectious disease journal
2025

Exploring parents' knowledge, attitudes and practices on honey and botulism in the West Bank, Palestine: a cross-sectional study.

Annals of medicine
2025

Infant Botulism in Israel: A Rare Disease That Still Exist.

The Israel Medical Association journal : IMAJ
2025

Global Occurrence of Infant Botulism: 2007-2021.

Pediatrics
2025

Botulinum Neurotoxins as Two-Faced Janus Proteins.

Biomedicines
2025

Dry and dusty outback: infant botulism.

BMJ case reports
2025

Conflicting Clinical Presentation of Infection with Clostridium botulinum and Clostridium perfringens in a 5-Month-Old Infant.

Journal of pediatrics. Clinical practice
2025

[The application analysis of antitoxin therapy in severe infant botulism].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

[Infant botulism: an underestimated problem. A review].

Terapevticheskii arkhiv
2024

First case of infant botulism in Sicily-case report.

Italian journal of pediatrics
2024

Elevated incidence of infant botulism in a 17-county area of the Mid-Atlantic region in the United States, 2000-2019, including association with soil types.

Applied and environmental microbiology
2025

Outpatient Infant Botulism in the United States, 1976-2021.

The Journal of pediatrics
2024

Prevalence of Clostridium botulinum in Retail Peanut Butters from a 2007 Survey in Ottawa, Canada.

Current microbiology
2024

Infant Botulism: In Search of Clostridium botulinum Spores.

Current microbiology
2024

Fecal Microbiota Transplantation for Severe Infant Botulism, China.

Emerging infectious diseases
2024

Overview of anaerobic infections in children and their treatment.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2024

Dissecting and tracing the gut microbiota of infants with botulism: a cross sectional and longitudinal study.

Frontiers in microbiology
2024

Case report: Aberrant fecal microbiota composition of an infant diagnosed with prolonged intestinal botulism.

Gut pathogens
2024

From Rarity to Recognition: Infantile Botulism and the Broad Spectrum of Differential Diagnoses.

Case reports in pediatrics
2024

[Clinical characteristics and prognosis of 8 cases of severe infant botulism].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

Closed genome sequence of Clostridium botulinum type B1 strain isolated from an infant botulism case in the United States.

Microbiology resource announcements
2023

Knowledge, attitude and practice among mothers on the relationship between honey and botulism in Saudi Arabian infants: a cross-section study.

Annals of medicine
2023

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain.

Microbiology spectrum
2023

Viable Clostridium botulinum spores not detected in the household dust of major Canadian cities.

Epidemiology and infection
2023

Recurrent Infant Botulism Complicated by Necrotizing Enterocolitis.

Pediatric neurology
2023

Duration of Fecal Excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from Infant Botulism.

The Journal of pediatrics
2023

Botulism in the 21st Century: A Scoping Review.

The Brown journal of hospital medicine
2023

Infant Botulism, Israel, 2007-2021.

Emerging infectious diseases
2022

Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997-2019.

Toxins
2023

Infant botulism: a descriptive study in a pediatric intensive care unit.

Archivos argentinos de pediatria
2022

First confirmed case of infant botulism caused by Clostridium botulinum type A(B) in a 10-month-old infant in Hanoi, Vietnam.

IJID regions
2022

Fixed Pupils in Infant Botulism.

Neuropediatrics
2023

Dual-Toxin ("Bivalent") Infant Botulism in California, 1976-2020: Epidemiologic, Clinical, and Laboratory Aspects.

The Journal of pediatrics
2022

Comparative whole-genome sequence analysis of a BoNT/B5-producing Clostridium botulinum isolate from an infant botulism case of unknown source in Osaka, Japan.

FEMS microbiology letters
2022

Probiotic Potential of Clostridium spp.-Advantages and Doubts.

Current issues in molecular biology
2022

Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani.

Toxins
2022

Infant botulism: Report of a misleading case and important key messages.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2022

Evaluation and Optimization of Microdrop Digital PCR for Detection of Serotype A and B Clostridium botulinum.

Frontiers in microbiology
2022

Genomic and Phenotypic Characterization of Clostridium botulinum Isolates from an Infant Botulism Case Suggests Adaptation Signatures to the Gut.

mBio
2021

Infant Botulism: Checklist for Timely Clinical Diagnosis and New Possible Risk Factors Originated from a Case Report and Literature Review.

Toxins
2021

Infantile Hypotonia: A Case of Spinal Muscular Atrophy With Respiratory Distress Type 1 Presenting As Infant Botulism.

Cureus
2022

6-month old with new-onset weakness - consider infant botulism.

Archives of disease in childhood
2021

The Role of the Pharmacist in the Treatment of Infantile Botulism.

HCA healthcare journal of medicine
2021

Closed Genome Sequence of Clostridium botulinum Strain IBCA10-7060 Type Bh.

Microbiology resource announcements
2021

A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979-2019.

Canada communicable disease report = Releve des maladies transmissibles au Canada
2021

Clostridium botulinum Type B Isolated From a Wound Botulism Case Due to Injection Drug Use Resembles Other Local Strains Originating From Hawaii.

Frontiers in microbiology
2021

Genomic Characterization of Strains From a Cluster of Infant Botulism Type A in a Small Town in Colorado, United States.

Frontiers in microbiology
2021

Infant botulism: an underestimated threat.

Infectious diseases (London, England)
2021

Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
2021

Genetic Characterization of Clostridium botulinum Isolated from the First Case of Infant Botulism in Korea.

Annals of laboratory medicine
2021

CRISPR-Cas9-Based Toolkit for Clostridium botulinum Group II Spore and Sporulation Research.

Frontiers in microbiology
2021

First confirmed case of infant botulism in Africa, caused by a dual-toxin-producing Clostridium botulinum strain.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2020

Toxemia in Human Naturally Acquired Botulism.

Toxins
2020

BOTOX injection to treat strabismus after infant botulism type B infection.

American journal of ophthalmology case reports
2020

Descriptive Epidemiology of Infant Botulism in California: The First 40 Years.

The Journal of pediatrics
2020

Seven-Year Case-Control Study in California of Risk Factors for Infant Botulism.

The Journal of pediatrics
2020

[Clinical analysis and laboratory diagnosis of three cases with infantile botulism caused by Clostridium botulinum type B].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2020

Two Cases of Infant Botulism Presenting with Altered Mental Status.

Hawai'i journal of health &amp; social welfare
2020

Infant botulism in Singapore.

Singapore medical journal
2020

Human Botulism in France, 1875-2016.

Toxins
2020

The First Reported Case of Infant Botulism in Korea: Treatable Infantile Neuromuscular Disease.

Journal of Korean medical science
2020

Adult Intestinal Toxemia Botulism.

Toxins
2019

The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA.

Toxins
2019

Lambert-Eaton Myasthenic Syndrome, Botulism, and Immune Checkpoint Inhibitor-Related Myasthenia Gravis.

Continuum (Minneapolis, Minn.)
2019

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.

PloS one
2019

Clostridium botulinum infection in an exclusively breast-fed infant.

Pediatrics international : official journal of the Japan Pediatric Society
2020

Acute Neuromuscular Disorders in the Pediatric Intensive Care Unit.

Journal of child neurology
2019

Botulism - a rare but still present, life-threatening disease.

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne
2019

The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs.

Cellular microbiology
2019

Medical treatment for botulism.

The Cochrane database of systematic reviews
2019

Molecular Characterization of Clostridium botulinum Harboring the bont/B7 Gene.

Foodborne pathogens and disease
2019

Infant Botulism With Asymmetric Cranial Nerve Palsies.

Pediatric neurology
2019

Identification and characterization of Clostridium botulinum strains associated with an infant botulism case in China.

Anaerobe
2018

Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients.

Antimicrobial agents and chemotherapy
2018

Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?

Archives of disease in childhood
2018

Infant botulism: Two case reports and electroneuromyogram findings.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2018

Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.

Vaccine
2018

BabyBIG has BIG advantages for treatment of infant botulism.

The Journal of pediatrics
2018

Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.

Current microbiology
2017

Type F Infant Botulism: Investigation of Recent Clusters and Overview of This Exceedingly Rare Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2018

Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure.

The Journal of pediatrics
2018

More Clinical Mimics of Infant Botulism.

The Journal of pediatrics
2017

Characterization of the functional activity of botulinum neurotoxin subtype B6.

Microbiology and immunology
2017

Infant botulism in Denmark from 1995 to 2015.

Danish medical journal
2017

[Botulism: Diagnosis and Therapy].

Deutsche medizinische Wochenschrift (1946)
2017

Infant Botulism in the Very Young Neonate: A Case Series.

AJP reports
2017

[Infant botulism – why honey should be avoided for children up to one year].

Lakartidningen
2017

Towards Better Understanding of the Pathogenesis of Neuronal Respiratory Network in Sudden Perinatal Death.

Frontiers in neurology
2017

Molecular and Epidemiological Characterization of Infant Botulism in Beijing, China.

Biomedical and environmental sciences : BES
2017

Botulism in Italy, 1986 to 2015.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2016

Clostridium baratii: a rare case of pneumonia associated with an Alzheimer patient in Rio de Janeiro, Brazil.

JMM case reports
2017

Effective treatment of infant botulism on day 13 after symptom onset with human botulism antitoxin.

Journal of paediatrics and child health
2017

Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.

Cellular microbiology
2017

Flaccid paralysis in an infant associated with a dirty wound and application of honey.

BMJ case reports
2017

Trends in Outcomes and Hospitalization Charges of Infant Botulism in the United States: A Comparative Analysis Between Kids' Inpatient Database and National Inpatient Sample.

Pediatric neurology
2016

Neurotoxins from Clostridium botulinum (serotype A) isolated from the soil of Mendoza (Argentina) differ from the A-Hall archetype and from that causing infant botulism.

Toxicon : official journal of the International Society on Toxinology
2016

Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Genome biology and evolution
2016

A penicillin- and metronidazole-resistant Clostridium botulinum strain responsible for an infant botulism case.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2016

[Clinical analysis of three cases with infant botulism and review of literature].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2016

Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.

The Journal of infectious diseases
2015

Abnormal Neuroimaging in a Case of Infant Botulism.

Frontiers in pediatrics
2016

Stimulated jitter analysis for the evaluation of neuromuscular junction disorders in children.

Muscle &amp; nerve
2015

Characterizing the fecal microbiota of infants with botulism.

Microbiome
2015

Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism.

Biochemical pharmacology
2015

[Intoxication of botulinum toxin].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
2017

Microbiology and foodborne pathogens in honey.

Critical reviews in food science and nutrition
2015

Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.

Journal of clinical microbiology
2015

Stimulated jitter in infant botulism.

Muscle &amp; nerve
2015

Infant botulism: review and clinical update.

Pediatric neurology
2015

Notes from the field: infant botulism caused by Clostridium baratii type F - Iowa, 2013.

MMWR. Morbidity and mortality weekly report
2015

Consumers' Perception and Knowledge of Food Safety: Results of Questionnaires Accessible on IZSalimenTO Website.

Italian journal of food safety
2015

Stimulated jitter analysis in the early diagnosis of infant botulism.

Muscle &amp; nerve
2016

A case of infant botulism in a 4-month-old baby.

QJM : monthly journal of the Association of Physicians
2015

Botulism mortality in the USA, 1975-2009.

The botulinum journal
Ver todos os 336 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Botulismo infantil.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Botulismo infantil

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The unsung hero: ntnh gene as complementary botulism marker.
    Frontiers in cellular and infection microbiology· 2026· PMID 41809992mais citado
  2. Multistate Infant Botulism Outbreak Associated with Powdered Infant Formula.
    NEJM evidence· 2026· PMID 41739440mais citado
  3. More Than Just a Floppy Baby: Maintaining High Clinical Suspicion of Infant Botulism.
    Cureus· 2026· PMID 41728439mais citado
  4. Infant Honey Feeding and Associating Sociodemographic and Clinical Factors: Are there risks for infant botulism in Oman?
    Sultan Qaboos University medical journal· 2026· PMID 41659220mais citado
  5. Clostridioides difficile colonization of Twin Patients Recovering From Infant Botulism.
    Anaerobe· 2026· PMID 41610908mais citado
  6. Infant Botulism and Honey Exposure: Global Epidemiology, Prevention Policies, and Communication Strategies.
    Acta Paediatr· 2026· PMID 41964486recente
  7. [Evaluation of ventilatory muscles in infants with severe botulism].
    Andes Pediatr· 2025· PMID 41842776recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:178478(Orphanet)
  2. MONDO:0015804(MONDO)
  3. GARD:20150(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q3643111(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Botulismo infantil
Compêndio · Raras BR

Botulismo infantil

ORPHA:178478 · MONDO:0015804
Prevalência
Unknown
CID-10
A05.1 · Botulismo
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0238027
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades